What does this research mean for the field?

Medicaid organ transplant beneficiaries experience significantly lower post-transplantation survival compared to privately insured patients, potentially due to late referral and more severe organ failure at the time of listing. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To examine the proportion of solid organ transplantations performed in Medicaid beneficiaries and evaluate five-year post-transplantation survival relative to Medicare and private insurance coverage.

July 26, 2016Journal of the American College of SurgeonsOpen Access

Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes

View Full Paper

Ask AI

Bookmark

To examine the proportion of solid organ transplantations performed in Medicaid beneficiaries and evaluate five-year post-transplantation survival relative to Medicare and private insurance coverage.
Retrospective cohort analysis of adult heart, lung, liver, and kidney transplant recipients (n = 169,194) in the Scientific Registry of Transplant Recipients between 2002 and 2011.
Recipients were categorized by payer status into private insurance, Medicare, or Medicaid cohorts.
Five-year post-transplantation survival was estimated using Kaplan-Meier curves and compared via log-rank tests and organ-specific Cox proportional hazards models adjusted for donor and recipient characteristics.
Medicaid recipients represented 8.6% of transplant recipients and received fewer transplants than expected for heart (observed-to-expected [O/E] ratio = 0.89; 95% CI, 0.44–1.49), lung (O/E = 0.57; 95% CI, 0.22–1.06), and kidney (O/E = 0.32; 95% CI, 0.08–0.72), but exceeded expectations for liver (O/E = 1.21; 95% CI, 0.68–1.90).
Medicaid beneficiaries were listed with more severe organ failure and experienced shorter wait times, but demonstrated significantly lower post-transplantation survival than privately insured recipients across all organs.
Post-transplantation survival in Medicaid recipients was similar to Medicare recipients for heart, liver, and kidney transplants, but was lower for lung transplants.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective cohort study reveals lower five-year post-transplant survival in Medicaid beneficiaries across solid organ recipients, suggesting late referral drives worse clinical outcomes.

Cite This Study

DuBay et al. (2016) studied this question.

synapsesocial.com/papers/6aaa668e561c8ccf3ff29320 https://doi.org/10.1016/j.jamcollsurg.2016.07.004

View Full Paper

Ask AI

Bookmark

Implication

Retrospective cohort study reveals lower five-year post-transplant survival in Medicaid beneficiaries across solid organ recipients, suggesting late referral drives worse clinical outcomes.

Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes

Key Points

Discussion

Implication

Cite This Study

Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider